Francisco Pimentel

Mastologista e Cirurgião de Mama. PhD em cirurgia oncoplastica. Co-fundador do BBREAST. Portal Câncer de Mama Brasil. Afiliado SBM, ASCO, ESMO e ASBrS

[Francisco Pimentel @DrPimentel_]

Quantas mortes por câncer de mama HER2+ poderiam ser evitadas no SUS?

Estudo na The Breast projeta, em 8 anos, 934 mortes a menos com T-DM1 adjuvante (−26%) e 1.216 a menos com pertuzumabe + T-DM1 (−34%).

https://t.co/rzjSTlhHXq

[Francisco Pimentel @DrPimentel_]

https://t.co/cGNvPEgWkZ via @researchgate https://t.co/cGNvPEgWkZ

[NEJM @NEJM]

Among patients with breast cancer, the benefit of regional nodal irradiation in those whose axillary nodes become pathologically tumor free after neoadjuvant chemotherapy is unclear.

Research findings from a phase 3 trial are summarized in a new Quick Take video. https://t.co/xA0xfUC96i

[NEJM @NEJM]

In women with node-positive breast cancer whose nodes became free of disease after neoadjuvant therapy, regional nodal irradiation did not reduce breast cancer recurrence or improve survival. Full results from a phase 3 trial: https://t.co/M5HIEFodxB

[Francisco Pimentel @DrPimentel_]

https://t.co/6bcKx74hXR

[Francisco Pimentel @DrPimentel_]

https://t.co/BtVjqlBfhN

[Eric Topol @EricTopol]

How can we reduce breast cancer and its adverse outcomes?
Individualized risk assessment, mentions polygenic risk score
🆕 @TheLancet Commmission 55-page report
https://t.co/oIoUuEpNR7
Risk factors: obesity, alcohol, physical inactivity, not breastfeeding (see Figure)

[Francisco Pimentel @DrPimentel_]

https://t.co/pdK6i2D249

[Francisco Pimentel @DrPimentel_]

My research is available on @ResearchGate: https://t.co/1j0MNokOWZ

[OncoNews @PortalOnconews]

Francisco Pimentel, mastologista na Hospital Geral de Fortaleza (HGF), é primeiro autor de estudo publicado no periódico Plastic and Reconstrutive Surgery – Global Open.
📲Leia mais: https://t.co/4qo7b45pRg
@DrPimentel_ @oncoclinicas @FZerwes @PUCRS @edumillen

#oncologia #onco

[NEJM Evidence @NEJMEvidence]

“…the subcutaneous administration of adjuvant denosumab 60 mg twice per year led to a modest benefit…in postmenopausal patients with hormone receptor–positive breast cancer who were receiving aromatase inhibitor treatment." https://t.co/uuvf0gde5O

#Brustkrebs #OncoTwitter

[Francisco Pimentel @DrPimentel_]

Divulgando este evento semana que vem organizado pelo grupo do Hospital do Amor (Barretos/SP), coordenado por @dridamjr a quem agradeço convite. Discutiremos câncer de mama em pacientes com mutação hereditária. Um privilégio participar. #cancerdemama

[JCO Global Oncology @JCOGO_ASCO]

📣 What are the relevant evidence-based data and recommendations on the management of early breast cancer #eBC during the #COVID19 pandemic❓

Read in #JCOGO ➡️ https://t.co/1OLQJj93nr #BCSM #OncTwitter #MedTwitter #LMIC #GlobalOnc @DrPimentel_

[Francisco Pimentel @DrPimentel_]

@JCOGO_ASCO 👊🏻👊🏻👊🏻

[Francisco Pimentel @DrPimentel_]

New standard ?

[Francisco Pimentel @DrPimentel_]

@TheNotoriousMMA Good luck, Champ !

[Francisco Pimentel @DrPimentel_]

Pandemia afeta mulheres com câncer de mama https://t.co/N0lDNWbqyG

[Francisco Pimentel @DrPimentel_]

@joaoamoedonovo Brasil é o primeiro no mundo em mortes por milhão em países com população acima de 10 milhões de habitantes. Neste contexto, já somos o 8 lugar, atrás apenas de países pequenos. Fonte: Johns Hopkins.

[Francisco Pimentel @DrPimentel_]

Pandemia afeta mulheres com câncer de mama https://t.co/N0lDNWbqyG

[Francisco Pimentel @DrPimentel_]

@Rconstantino No Brasil, 1873 por milhao. Até ontem.